Navigation Links
Youth and Adults Throughout Illinois Urge Governor Blagojevich and Congress: Invest Our Tax Dollars Wisely
Date:4/15/2008

ir kids, and lawmakers to invest more wisely in programs that empower teens, support teachers, and assist parents.

"I can't imagine people paying their taxes this year would be happy to know how their tax dollars are being spent," says Ebony Hamlin, 18, a senior at Prosser Academy in Chicago. "It's time to get real and stop playing politics with our lives. We deserve sexual health education that meets our needs now and for our future."

Recent reports have highlighted alarming rates of sexually transmitted infections and rising birth rates among teens. Meanwhile, governors of 17 states, including Iowa, Wisconsin, Virginia, and Arizona, have recognized the misuse of public funds for abstinence-only programs that have no impact on the health outcomes of their youth and decided to reject Title V funds. Furthermore, Title V also requires states to match $3 for every $4 received from the federal government.

Evidence has been mounting that these programs are ineffective. Last year, a Congressionally mandated evaluation conducted by Mathematica of federally funded programs showed that these programs had no impact on student behavior. Students in abstinence-only programs were no less likely to engage in sexually activity, have fewer sexual partners, or use a condom more often. These programs have also been shown to be insufficient. In a review by Illinois experts of the curricula being used in Illinois schools, the curricula most frequently used in classrooms and paid for through abstinence-only funding, ranked in the bottom third when matched up with the standards and components for school-based sexual health education recommended by the national medical and public health associations.

More information about the Illinois Caucus for Adolescent Health is available at http://www.icah.org.

The Illinois Caucus for Adolescent Health (ICAH) was founded in 1977 as the Illinois Caucus on Teenage Pregn
'/>"/>

SOURCE Illinois Caucus for Adolescent Health
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. More than two-thirds of sexually active NYC youth use condoms, but other forms of birth control lag
2. Study documents rapid increase in youth bipolar disorder diagnoses
3. Rates of bipolar diagnosis in youth rapidly climbing, treatment patterns similar to adults
4. Youth Drug Use at a Five Year Low, New Survey Shows
5. Jump in Youth Suicide Prompts National Childrens Charity KidsPeace to Issue Tips on Prevention, Warning Signs
6. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
7. $8,000 Winning Bids at Governors Livestock Auction to Benefit College-Bound Youth and Homeless
8. Nourishment Is Essential to a Youthful Appearance. Time to Feed Your Face with Serum_G
9. Prime Access Creates Groundbreaking Ads Targeting Urban Teens for the White Houses National Youth Anti-Drug Media Campaign
10. Safe Blood for Africa Foundations African Club 25 Greatly Reducing HIV Infections in African Youth
11. Victims of child maltreatment more likely to perpetrate youth violence, intimate partner violence
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4VisEn Launches New OsteoSense 28R 29 800 and VivoTag 28R 29 800 Fluorescence Molecular Imaging Agents 6408 1VisEn Launches New OsteoSense 28R 29 800 and VivoTag 28R 29 800 Fluorescence Molecular Imaging Agents 6408 2VerifyNow 28R 29 System Highlighted in POPular Study Comparing Platelet Reactivity Tests 6404 1VerifyNow 28R 29 System Highlighted in POPular Study Comparing Platelet Reactivity Tests 6404 2Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research 6400 1Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research 6400 2Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research 6400 3